Modified Fluoroquinolones as Antimicrobial Compounds Targeting Chlamydia trachomatisShow others and affiliations
2022 (English)In: International Journal of Molecular Sciences, ISSN 1661-6596, E-ISSN 1422-0067, Vol. 23, no 12, article id 6741Article in journal (Refereed) Published
Abstract [en]
Chlamydia trachomatis causes the most common sexually transmitted bacterial infection and trachoma, an eye infection. Untreated infections can lead to sequelae, such as infertility and ectopic pregnancy in women and blindness. We previously enhanced the antichlamydial activity of the fluoroquinolone ciprofloxacin by grafting a metal chelating moiety onto it. In the present study, we pursued this pharmacomodulation and obtained nanomolar active molecules (EC50) against this pathogen. This gain in activity prompted us to evaluate the antibacterial activity of this family of molecules against other pathogenic bacteria, such as Neisseria gonorrhoeae and bacteria from the ESKAPE group. The results show that the novel molecules have selectively improved activity against C. trachomatis and demonstrate how the antichlamydial effect of fluoroquinolones can be enhanced.
Place, publisher, year, edition, pages
MDPI, 2022. Vol. 23, no 12, article id 6741
Keywords [en]
8-hydroxyquinoline, antibacterial, bactericidal, inhibitors, iron
National Category
Microbiology in the medical area
Identifiers
URN: urn:nbn:se:umu:diva-203178DOI: 10.3390/ijms23126741ISI: 000818267400001PubMedID: 35743189Scopus ID: 2-s2.0-85132015511OAI: oai:DiVA.org:umu-203178DiVA, id: diva2:1727569
2023-01-162023-01-162023-01-16Bibliographically approved